0000908662-15-000277.txt : 20150805 0000908662-15-000277.hdr.sgml : 20150805 20150805172315 ACCESSION NUMBER: 0000908662-15-000277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150803 FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Gustav CENTRAL INDEX KEY: 0001397709 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 151030043 MAIL ADDRESS: STREET 1: DYAX CORP. STREET 2: 300 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-03 0000907562 DYAX CORP DYAX 0001397709 Christensen Gustav C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 1 1 0 0 CEO and President Common Stock 2015-08-03 4 M 0 76045 1.91 A 288545 D Common Stock 2015-08-03 4 G 0 50000 0 D 238545 D Common Stock 2015-08-03 4 M 0 250000 2.09 A 488545 D Common Stock 2015-08-03 4 S 0 86315 24.1876 D 402230 D Common Stock 2015-08-03 4 M 0 67967 3.00 A 470197 D Common Stock 2015-08-04 4 S 0 70090 23.8671 D 400107 D Common Stock 2015-08-05 4 S 0 93595 23.5409 D 306512 D Stock Option (right to buy) 1.91 2015-08-03 4 M 0 76045 0 D 2021-02-10 Common Stock 76045 523955 D Stock Option (right to buy) 2.09 2015-08-03 4 M 0 250000 0 D 2019-05-14 Common Stock 250000 0 D Stock Option (right to buy) 3.00 2015-08-03 4 M 0 67967 0 D 2023-02-07 Common Stock 67967 332033 D The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.46, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2. The options were fully exercisable as of February 10, 2015. The options were fully exercisable as of May 14, 2013. /s/ Andrew D. Ashe as attorney-in-fact 2015-08-05